Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer
Clinical trial NCT00191763 · COMPLETED
Trial details
- NCT number
- NCT00191763
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.